- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Foster City Today
By the People, for the People
United Super Pty Ltd Increases Stake in Gilead Sciences
The construction and building unions' superannuation fund grew its holdings in the biopharmaceutical company by 132.1%.
Published on Mar. 8, 2026
Got story updates? Submit your updates here. ›
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD) by 132.1% during the third quarter, according to the company's filing with the Securities and Exchange Commission. The fund now owns 25,300 shares of the biopharmaceutical company's stock, valued at $2,808,000.
Why it matters
Gilead Sciences is a major player in the biopharmaceutical industry, particularly in the areas of antiviral therapies for HIV and viral hepatitis. The increase in United Super's stake suggests the fund sees long-term value in Gilead's business and product pipeline.
The details
United Super Pty Ltd added 14,400 shares of Gilead Sciences to its portfolio during the third quarter, bringing its total holdings to 25,300 shares. This represents a 132.1% increase in the fund's stake in the company. Gilead Sciences is a global biopharmaceutical firm focused on developing and commercializing medicines in areas of high unmet medical need, including antiviral therapies, oncology, cell therapy, and inflammatory diseases.
- The stake increase occurred during the third quarter of the reporting period.
The players
United Super Pty Ltd
An Australian superannuation fund that serves the construction and building unions.
Gilead Sciences, Inc.
A global biopharmaceutical company focused on developing and commercializing medicines in areas of high unmet medical need, including antiviral therapies, oncology, cell therapy, and inflammatory diseases.
The takeaway
United Super's increased investment in Gilead Sciences reflects the fund's confidence in the biopharmaceutical company's long-term prospects, particularly in its core antiviral therapies business.
